VerImmune
Pre-clinicalVerImmune is developing Anti-Tumor Immune Redirection (AIR): a breakthrough therapy that redirects immune memory against pathogens or childhood vaccines to target cancer.
Founded
2019
Focus
Small Molecules
About
VerImmune is developing Anti-Tumor Immune Redirection (AIR): a breakthrough therapy that redirects immune memory against pathogens or childhood vaccines to target cancer.
Funding History
1Total raised: $5.5M
Seed$5.5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2019
LocationRockville, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile